Laryngeal mucosa-associated lymphoid tissue (MALT) lymphoma is rare, with only 25 cases reported in the literature. This report presents a case of laryngeal MALT lymphoma in a 35-year-old female with a 6-year history of progressively worsening hoarseness. MALT lymphoma was diagnosed based on biopsy and immunohistochemical analysis. The patient received two cycles of cyclophosphamide + epirubicin + vincristine + prednisone (CHOP) chemo therapy, which was ineffective. 18 F-fluoro deoxy glucose ( 18 F-FDG) positron emission tomography/ computed tomography (PET/CT) showed 18 F-FDG accumulation in the larynx only and identified stage IE lymphoma. CHOP chemotherapy was terminated and the patient was treated with radiotherapy. After 3 months (total radiation dose 27 Gy), 18 F-FDG PET/CT scan showed that the laryngeal lesion was in complete remission.
Introduction
Laryngeal mucosa-associated lymphoid tissue (MALT) lymphoma is rare. To our knowledge, only 25 cases of laryngeal MALT lymphoma have been described in the literature. 1 -22 Chronic Helicobacter pylori infection is associated with gastric MALT lymphoma, suggesting a role for chronic inflammatory disease in the aetiology of MALT. 23 Caletti et al. 13 reported the case of a patient with concomitant laryngeal MALT lymphoma and H. pylori-related gastric MALT lymphoma. Due to the limited number of cases, chronic inflammatory processes in the larynx have therefore, requires further investigation.
This report presents a case of laryngeal MALT lymphoma that was initially diagnosed as chronic laryngitis and describes the changes in therapeutic strategy made in response to 18 F-FDG PET/CT scan findings. A 35- year-old female presented with a 6-year history of hoarseness that had become progressively worse over the past 4 years. The patient also reported the feeling of a foreign body in the throat, had a cough, and produced sputum that sometimes contained blood. She had no history of dyspnoea, dysphagia or autoimmune disorders. In June 2005, stroboscopy identified a right false vocal cord polypoid mass. Biopsy revealed the lesion to be chronic laryngitis and the mass was completely excised using a carbon dioxide laser. Routine pathological examination suggested that the lesion could be lymphoma, but re-evaluation by the Department of Pathology, First Affiliated Hospital, College of Medicine, Zhejiang University (Hangzhou, China) found no characteristics indicative of lymphoma. The patient's voice improved after surgery and a postoperative CT scan of the larynx showed normal findings. The hoarseness continued intermittently when the patient had a cold or overused her voice. A CT scan of the larynx was normal in July 2007, but the patient presented with progressive hoarseness and a choking sensation in her chest in August 2007, which was not investigated further.
Case report
In April 2011, the patient attended the Department of Otolaryngology, First Affiliated Hospital, College of Medicine, Zhejiang University, due to aggravated hoarseness. Stroboscopy revealed a smooth mass in the left aryepiglottic fold and swelling in the bilateral false vocal cord ( Fig.  1) . A CT scan of the larynx identified a 1.6 × 2.0 cm soft tissue mass in the left aryepiglottic fold, with heterogeneous density that was mildly enhanced on contrast-enhanced imaging. The mass had not invaded the laryngeal cartilage or muscle ( Fig. 2 ). Direct laryngoscopy under general anaesthesia (on 14 April 2011) confirmed a 1.6 × 2.0 cm smooth mass in the left aryepiglottic fold and swelling of the bilateral ventricular fold that presented as a polypoid. The glottis, subglottis and hypopharynx were normal. Histopathological examination of frozen sections showed active proliferation of lymphatic tissues, but lymphoma could not be diagnosed. Due to the location of the tumour in multiple sites, it was not possible to excise the entire tumour by direct laryngoscopy, and a semiconductor laser was used in a debulking procedure (Fig.  3 ). The postoperative course was uneventful. K Zhao, Y-Z Luo, S-H Zhou et al. 18 
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Histopathological examination of the tumour demonstrated diffuse infiltration of small lymphoid cells under the mucosa and lymphoid follicle plasmacytoid differentiation ( Fig. 4A ). Immunohistochemical staining revealed that these lymphocytes were mainly B cells (CD3 + , CD20 + , CD79a + , CD43 + , B cell lymphoma-2 [Bcl-2] + , CD5 -, CD10and CD23 -) ( Fig. 4B, 4C , 4D). These features indicated a marginal-zone B cell lymphoma (MALT lymphoma).
The patient received two 30-day cycles of chemotherapy using the CHOP protocol (0.8 g/m 2 cyclophosphamide, day 1; 90 mg/m 2 epirubicin, day 1; 1.4 mg/m 2 vincristine, day 1; and 40 mg/m 2 per day prednisone, days 1 -5; all drugs administered orally). Stroboscopy showed that the left aryepiglottic fold and bilateral false vocal cords had continued to swell, and 18 F-FDG PET/CT was performed. This procedure revealed localized 18 F-FDG accumulation in the larynx (maximum standardized uptake value 3.28) . No other areas of accumulation were observed (Fig. 5 ). The tumour was diagnosed as stage IE according to the Ann Arbor staging system. 37 Radiotherapy was initiated on 10 May 2011. Follow-up stroboscopy ( Fig. 6 ) and 18 F-FDG PET/CT were performed after 3 months (total radiation dose 27 Gy) with no evidence of tumour recurrence.
Approval to report the patient's data was obtained from the Institutional Review Board of The First Affiliated Hospital, College of Medicine, Zhejiang University.
Discussion
Mucosa-associated lymphoid tissue lymphoma belongs to the extranodal marginal-zone B cell lymphoma category of non-Hodgkin's lymphoma (NHL). 1 The most common site of MALT lymphoma is gastric, 25 but tumours have also been identified in the oesophagus, 24, 25 breast, 25 central nervous system, 27 prostate, 28 orbit, 25, 30 lungs, 25, 32 thyroid gland 33 and liver. 34 Primary laryngeal MALT lymphoma was first reported in 1990. 22 These tumours are rare and little is known about their clinical course and optimal treatment.
A systematic review of the Englishlanguage literature published between January 1990 and December 2011 was undertaken to identify cases of laryngeal MALT lymphoma. The MEDLINE ® /PubMed ® databases were searched using the key words: 'MALT lymphoma, head and neck'; 'MALT lymphoma, larynx'; 'non-Hodgkin lymphoma, head and neck'; 'non-Hodgkin lymphoma, larynx'; and 'mucosa-associated lymphoid tissue lymphoma, larynx or head and neck'. The search identified 25 cases of primary laryngeal MALT lymphoma. 1 -22 Details of these 25 cases, together with the present case, are shown in Table 1 . The cases included nine males and eight females (patient gender was not reported in five cases 5, 12, 15, 16, 20 ) . The age of the patients at presentation ranged from 34 to 78 years (mean 49 years; data not available for five patients 5, 12, 15, 16, 20 ) . Information regarding tumour location was available for 22 patients: 17 (77.3%) supraglottic tumours, four (18.2%) subglottic and one (4.5%) glottic. This regional distribution was associated with the distribution of laryngeal MALT tissue, which mainly occurs in the supraglottis. 3 The majority of patients complained of hoarseness or had no specific symptoms. Emergency tracheostomy was performed in three patients because of severe dyspnoea. 4, 9, 21 Mucosa-associated lymphoid tissue lymphoma can originate in different organs and, therefore, has a diverse pathogenesis. 25 The time from onset of symptoms to treatment of laryngeal MALT lymphoma in the 25 previously reported cases 1 -22 and one new case included in this review ranged from MALT lymphoma may be associated with autoimmune diseases, 5 including systemic lupus erythematosus 3 and Sjögren's syndrome. 9 It is unclear which is the most effective first-line treatment for laryngeal MALT lymphoma. The current review found that patients responded to a variety of therapeutic approaches (Table 1) . 1,3,4,6 -11,13 -19,21,22 CHOP chemotherapy was shown to be ineffective in the present case and in a case of supraglottic MALT lymphoma reported by Kato et al., 19 but radiotherapy led to the successful elimination of the tumour. Monitoring the effect of the initial therapy, therefore, enables appropriate therapeutic decisions. 18 F-FDG PET/CT has been shown to be useful in the diagnosis, staging, restaging and treatment of NHL, 25, 36, 38 but the validity of 18 F-FDG PET/CT for MALT lymphoma remains unclear. A number of studies have shown that 18 F-FDG uptake in MALT lymphoma depends on the disease site. 23 -36 A systematic review of the English- (Table  2) , 2,5,8,23 -36 three of which included tumours located in the larynx (Table 2) . 2, 5, 8 Of the 141 patients for whom PET/CT data were available (including the current case), 95 (67%) showed 18 F-FDG uptake. 2,5,8,23 -34 Uptake of 18 F-FDG was lower in gastric MALT lymphoma than in tumours at other sites. 25 In the larynx, seven cases from four reports (including the present case) showed 18 F-FDG avidity. 2, 3, 5 In the present case, PET/CT showed 18 F-FDG accumulation in the larynx only and revealed the tumour to be stage IE. As local radiotherapy at a dose of 25 -30 Gy had been shown to be an effective treatment for stage I or II MALT lymphoma at a variety of sites including the larynx, 10, 14, 16, 17, 28, 39 CHOP chemotherapy was terminated and radiotherapy was initiated. After 3 months, 18 F-FDG PET/CT showed that the laryngeal lesions of the present case were in complete remission after 27 Gy of irradiation.
In conclusion, 18 F-FDG PET/CT was useful for staging the rare laryngeal form of MALT lymphoma and provided a basis for altering the therapeutic strategy and evaluating the response to radiotherapy. These findings are in agreement with the opinion of Kishi et al. 24 that chemotherapy is not effective for MALT lymphoma and is, therefore, not recommended as the first-line treatment.
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